CRONOS GROUP INC. ANNOUNCES FIRST QUARTER 2018 RESULTS Q1 2018 total sales of $2.9 million, up 473% year over year Cannabis oil sales represent 29% of domestic medical patient...
Cronos Group Inc. Announces Fourth Quarter and Fiscal Year 2017 Results Q4 2017 sales of $1.6 million, up 274% year over year FY 2017 sales of $4.1 million, up 636% year...
With Canadian licensed producers under intense selling pressure over the past several weeks, insiders stepped up at three licensed producers, making large purchases over the past week or so...
Cronos Group Announces Closing of Previously Announced $100 Million Bought Deal TORONTO, April 6, 2018 /PRNewswire/ – Cronos Group Inc. (NASDAQ, TSX-V: CRON) (“Cronos Group” or the “Company”) is...
After a massive 17.7% decline in February, the Canadian Cannabis LP Index recovered just some of the losses in March, rallying 0.8% after having been up more than 13% earlier in...
After the close, Cronos Group (TSXV: CRON) (NASDAQ: CRON) filed a Form F-10 with the SEC, indicating that it is planning to sell shares in the United States in...
Cannabis Giants Join Forces in Cross Border Venture TORONTO, March 19, 2018 /CNW/ – Cronos Group Inc. (Nasdaq: CRON) (TSX-V: CRON) (“Cronos” or the “Company”) – With Canada on...
Cannabis stocks, as measured by the Global Cannabis Stock Index, plunged in February, more than reversing out the 10.7% gains in January by falling 26.7% to 115.33: The index,...
After a strong start to the year, with the Canadian Cannabis LP Index rising 17.7% in January, the benchmark reversed out the gains in February, declining 18.6% to leave...
Cronos Group to Begin Trading on Nasdaq Stock Exchange TORONTO, Feb. 26, 2018 /CNW/ – Cronos Group Inc. (TSX-V: MJN) (OTC Nasdaq Int’l Designation: PRMCF) (“Cronos Group” or the...
Cronos Group Announces Launch of Cronos Australia with Grant of Two Licenses TORONTO, Feb. 5, 2018 /CNW/ – Cronos Group Inc. (TSX-V: MJN) (OTC Nasdaq Int’l Designation: PRMCF) (the “Group” or...
Peace Naturals Receives Dealer’s License Allowing for the Exportation of New Product Categories Cronos Group Inc. (TSXV: MJN) (OTC – Nasdaq Int’l Designation: PRMCF) (“Cronos Group” or the “Company”)...
In 2017, the first two exchange-traded funds (ETF) focused on publicly-traded cannabis stocks emerged, including Horizons Marijuana Life Sciences Index ETF (TSX: HMMJ) (TSX: HMMJ.U) (OTC: HMLSF) in April...
Cronos Group Inc. Announces $30 Million Bought Deal TORONTO, Jan. 2, 2018 /CNW/ – Cronos Group Inc. (TSX VENTURE: MJN) (“Cronos” or the “Company”) is pleased to announce that it has entered into a...
Health Canada has issued 84 licenses to date under Authorized Licensed Producers of Cannabis for Medical Purposes (ACMPR) and has indicated that it will ramp up to over 200 in...
Cannabis stocks surged 51.8% in December after a 58.3% gain in November. For the full year, the Cannabis Stock Index rose from 74.10 to 142.10, an increase of 91.8%: Like...
Cronos Group Inc. Reports Q3 2017 Financial Results 962% increase in Q3 2017 revenue over the comparable prior year period Establishing low-cost capacity through joint venture in Israel Strengthened...
Cronos Group Announces Closing of Previously Announced $17 Million Bought Deal TORONTO, Nov. 8, 2017 /CNW/ – Cronos Group Inc. (TSX-V: MJN) (OTC – Nasdaq Int’l Designation: PRMCF) (“Cronos...
Despite a flood of supply this month, Canadian LP stock performance stands out so far in October as investors have retreated somewhat from the overall sector. The Cannabis Stock...
Cronos Group Inc. Announces $15 Million Bought Deal TORONTO, Oct. 19, 2017 /CNW/ – Cronos Group Inc. (TSX VENTURE: MJN) (“Cronos” or the “Company”) is pleased to announce that...
Expansion of International Medical Cannabis Markets: Poland Guest post by Peter S. Murphy, Member, Eckert Seamans Cherin & Mellott, LLC This Summer, Poland became the twelfth country in the European...
Cronos Announces Exclusive Distribution Agreement with Pohl-Boskamp in Germany TORONTO, Oct. 12, 2017 /CNW/ – Cronos Group Inc. (TSX-V: MJN) (OTC – Nasdaq Int’l Designation: PRMCF) (“Cronos” or the...
Horizons Medical Marijuana Life Sciences ETF (TSX: HMMJ) (OTC: HMLSF), the world’s first and still only cannabis ETF, has adjusted its portfolio this month as its benchmark, the North...
Cronos Announces Private Placement of Common Shares TORONTO, Sept. 14, 2017 /CNW/ – Cronos Group Inc. (“Cronos” or the “Company”) (TSX Venture: MJN) (OTC – Nasdaq International Designation: PRMCF)...
Cronos Establishes International Low Cost Production in Israel TORONTO, Sept. 6, 2017 /CNW/ – Cronos Group Inc. (TSXV: MJN) (OTC: PRMCF) (“Cronos” or the “Company”) is pleased to announce...
